Shockwave Medical to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
20 12월 2023 - 10:30PM
Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the
development and commercialization of transformational technologies
for the treatment cardiovascular disease, announced today that the
company will be participating in the 42nd Annual J.P. Morgan
Healthcare Conference, which is being held from Monday, January 8
to Thursday, January 11, 2024, in San Francisco, CA.
Shockwave management is scheduled for a live presentation on
Wednesday, January 10, 2024, at 7:30 a.m. Pacific Time. Interested
parties may access a live and archived webcast of the event on the
"Investors" section of the company’s website at:
https://ir.shockwavemedical.com.
About Shockwave Medical, Inc.Shockwave Medical
is a leader in the development and commercialization of innovative
products that are transforming the treatment of cardiovascular
disease. Its first-of-its-kind Intravascular Lithotripsy (IVL)
technology has transformed the treatment of atherosclerotic
cardiovascular disease by safely using sonic pressure waves to
disrupt challenging calcified plaque, resulting in significantly
improved patient outcomes. Shockwave has also recently acquired the
Neovasc Reducer, which is under clinical investigation in the
United States and is CE Marked in the European Union and the United
Kingdom. By redistributing blood flow within the heart, the Reducer
is designed to provide relief to the millions of patients worldwide
suffering from refractory angina. Learn more at
www.shockwavemedical.com and www.neovasc.com.
Media Contact: Scott Shadiow
+1.317.432.9210sshadiow@shockwavemedical.com
Investor Contact:Debbie Kasterinvestors@shockwavemedical.com
Shockwave Medical (NASDAQ:SWAV)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
Shockwave Medical (NASDAQ:SWAV)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024